Enanta Pharmaceuticals ENTA
NASDAQ ENTA
$12.64 +0.03 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Enanta Pharmaceuticals (ENTA) Operating Margin (2012 - 2026)

Updated

Enanta Pharmaceuticals' Operating Margin came in at -120.04% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 16.87 percentage points from -103.16% a year earlier and down 50.96 percentage points from the prior quarter.

Analysis

Enanta Pharmaceuticals (ENTA) Operating Margin (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Enanta Pharmaceuticals reported Operating Margin of -89.99%, up 59.40 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was -130.65%, up 49.27 percentage points from FY2024.

  • Operating Margin carries a five-year change of -96.66 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Operating Margin was -179.92% in FY2024 (-6.69 pp), -173.23% in FY2023 (-29.50 pp), -143.74% in FY2022 (-30.86 pp) and -112.88% in FY2021 (-78.88 pp).
  • The five-year range for quarterly Operating Margin is -221.70% (fiscal Q2 2023) to -60.45% (fiscal Q1 2026).
  • Year-over-year, Operating Margin increased in six of the last eight quarters, with an average year-over-year change of +39.16 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in fiscal Q2 2026 (a gain of 95.25 percentage points), and the weakest in fiscal Q1 2022 (a drop of 71.24 percentage points).
  • Business Quant data shows ENTA's Operating Margin at -69.07% (Q2 2026), -60.45% (Q1 2026) and -121.56% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Enanta Pharmaceuticals 367.20 Mn -360.79 Mn - -120.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -120.04%
Mar 31, 2026 -69.07%
Dec 31, 2025 -60.45%
Sep 30, 2025 -121.56%
Jun 30, 2025 -103.16%
Mar 31, 2025 -164.32%
Dec 31, 2024 -138.82%
Sep 30, 2024 -204.38%
Jun 30, 2024 -134.58%
Mar 31, 2024 -192.13%
Dec 31, 2023 -193.78%
Sep 30, 2023 -163.90%
Jun 30, 2023 -194.33%
Mar 31, 2023 -221.70%
Dec 31, 2022 -127.25%
Sep 30, 2022 -133.13%
Jun 30, 2022 -167.05%
Mar 31, 2022 -180.85%
Dec 31, 2021 -109.99%
Sep 30, 2021 -143.06%
API Access

Enanta Pharmaceuticals Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ENTA&period=max&api_key=YOUR_API_KEY